New live performance format offers exclusive full-app visibility, multi-camera shows, ticketing, and tipping for creators
LOS ANGELES, Feb. 23, 2026 (GLOBE NEWSWIRE) — Stargaze Entertainment Group Inc. (“Stargaze” or the “Company”) (OTCQB: STGZ), a next-generation content creation and social platform designed to redefine talent discovery, today announced the launch of the Stargaze MAIN STAGE Live, an innovative live performance feature that allows artists to book a dedicated 30-minute show that broadcasts to the entire Stargaze Stage platform and other secondary streaming partners.
Unlike traditional live platforms where creators compete for attention in crowded feeds, Stargaze MAIN STAGE Live offers only one live show at a time. When an artist goes live, they own the spotlight—commanding the full focus of the app and the audience...
Societe Generale: Capital decrease and report on share buy-back
Written by Customer Service on . Posted in Public Companies.
CAPITAL DECREASE AND REPORT ON SHARE BUY-BACK
Regulated Information
Paris, 23 February 2026
Societe Generale announces a capital decrease through the cancellation of treasury shares and reports executed transactions within the framework of a share buy-back programme.
Capital decrease
On 16 February 2026, the Board of Directors, upon authorization of the Extraordinary General Meeting of 22 May 2024, decided to reduce Societe Generale’s share capital on 23 February 2026, by cancellation of 15,170,791 treasury shares. These shares were repurchased from 19 November 2025 to 6 February 2026 included, for the purpose of cancellation, for an amount of EUR 1 billion as announced on 17 November 2025.
The share capital of Societe Generale now amounts to EUR 939,654,993.75, divided into 751,723,995 ordinary shares, with a nominal value of EUR 1.25...
SAVE THE DATE – NACON CONNECT IS BACK ON MARCH 4, 2026
Written by Customer Service on . Posted in Public Companies.
– SAVE THE DATE –NACON CONNECT IS BACK ON MARCH 4, 2026
Lesquin, February 23, 2026 – NACON is pleased to invite players and the press to its annual online conference, NACON Connect, which will take place on March 4, 2026, at 8 p.m. CET. This key event will highlight the publisher-developer’s future releases as well as the latest from its accessories department. The program will include game announcements, the broadcast of new videos and gameplay presentations for anticipated titles such as Cthulhu: The Cosmic Abyss, The Mound, Edge of Memories and Endurance Motorsport Series.The conference will also be an opportunity to reveal new projects that will enrich NACON’s catalog in the coming months.
The broadcast will be live on NACON’s official channels on March 4 at 8:00 PM CET / 11:00 AM PST.
For a sneak peek,...
IS Fyrirtækjalánasjóður hs. – Ársreikningur 2025
Written by Customer Service on . Posted in Public Companies.
IS Fyrirtækjalánasjóður hs. er sérhæfður sjóður í rekstri Íslandssjóða hf. Sjóðurinn gaf út skuldabréf sem tekin voru til viðskipta hjá Nasdaq Iceland hf. í nóvember 2024.
Meðfylgjandi er ársreikningur sjóðsins fyrir árið 2025.Rekstrarniðurstaða sjóðsins á árinu 2025 var 214 milljónir kr. og eignir sjóðsins námu samtals um 8,4 milljörðum kr. í árslok 2025.
Ársreikningurinn var endurskoðaður af KPMG ehf. Það er álit endurskoðanda að ársreikningurinn gefi glögga mynd af afkomu sjóðsins á árinu 2025, fjárhagsstöðu hans 31. desember 2025 og breytingu á handbæru fé á tímabilinu, í samræmi við lög um ársreikninga og lög um rekstraraðila sérhæfðra sjóða.Nánari upplýsingar veitir:
Brynjólfur Stefánsson, brynjolfur@islandssjodir.isAttachmentÁrsuppgjör IS 31 12 2025 – IS Fyrirtækjalánasjóður
Aramis Group – Declaration of transactions on own shares conducted from February 16 to February 20, 2026
Written by Customer Service on . Posted in Public Companies.
PRESS RELEASE
Arcueil, February 23, 2026
Declaration of transactions on own shares conducted from February 16 to February 20, 2026
Within the framework of the authorizations granted by the General Assembly on February 3, 2026, to operate on its shares and in accordance with the regulations related to share buybacks, Aramis Group hereby declares the following purchases of own shares (FR0014003U94) made from February 16 to February 20, 2026 (excluding the liquidity contract):Name of the issuer
Issuer identifier code
Transaction date
Financial instrument identifier code
Total daily volume (in number of shares)
Daily weighted average purchase price of shares
MarketAramis Group
9695002Q984W0T41WB42
2026-02-16
FR0014003U94
4,850
4.1229
XPARAramis Group
9695002Q984W0T41WB42
2026-02-17
FR0014003U94
4,689
4.1760
XPARAramis Group
9695002Q984W0T41WB42
2026-02-18
FR0014003U94
4,769
4.1935
XPARAramis...
EXL and AWS collaborate on agentic AI initiative to reshape Sonos IT service management
Written by Customer Service on . Posted in Public Companies.
Embedding AI in Sonos workflows is creating a new benchmark for efficiency, operational intelligence and risk mitigation
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) — EXL [Nasdaq: EXLS], a global data and AI company, today announced a critical transformation initiative with Sonos (Nasdaq: SONO), the world’s leading sound experience company, and Amazon Web Services (AWS). This unique collaboration deploys agentic AI within Sonos IT service management (ITSM) workflows, aiming to create a new benchmark for efficiency, operational intelligence and risk mitigation. The initiative brings together Sonos innovative culture, EXL’s deep expertise in AI-led solutions and the powerful cloud infrastructure of AWS.
The initiative represents a significant step forward in applying sophisticated AI to real-world enterprise scenarios. By harnessing...
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
Written by Customer Service on . Posted in Public Companies.
LONDON and NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced that its abstract has been accepted for presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting, taking place May 3-7, 2026, in Denver, Colorado.
Chief Scientific Officer Raj Patil, Ph.D., will share the data in a presentation titled: “First-in-Human Study of Urcosimod to Treat Neuropathic Corneal Pain (NCP) Shows Clinically Meaningful Pain Reduction and Quality-of-Life Improvement in NCP Patients.”
This presentation highlights positive results from OKYO’s recently completed proof-of-concept Phase 2a...
Rubico Inc. Announces Agreement to Acquire an ECO MR Product Tanker Newbuilding with Time Charter Employment and Potential Gross Revenue Backlog of about $75 million
Written by Customer Service on . Posted in Public Companies.
ATHENS, Greece, Feb. 23, 2026 (GLOBE NEWSWIRE) — Rubico Inc. (Nasdaq: RUBI) (the “Company” or “Rubico”), a global provider of shipping transportation services specializing in the ownership of vessels, announced today that it has entered into an agreement with Central Mare Inc, an affiliate of Mr. Evangelos Pistiolis, (“the Seller”), to acquire 100% of the issued and outstanding shares of a Marshall Islands company (the “SPV”), counterparty to a ship building contract for a very-high specification 47,499 dwt Medium Range (“MR”) product/chemical oil tanker with Guangzhou Shipyard International Company Limited, scheduled for delivery during 2029.
The ship building contract effectiveness is subject to the issuance of a customary refund guarantee and the acquisition of the SPV is subject to conclusion of financing arrangements. Specifically,...
T3 Defense Brings in Former Rafael and Avnon Leadership to Lead Business Operations
Written by Customer Service on . Posted in Public Companies.
Appointments add decades of defense, security, and international program experience to T3 Defense’s executive team
NEW YORK and TEL AVIV, Israel, Feb. 23, 2026 (GLOBE NEWSWIRE) — T3 Defense Inc. (NASDAQ: DFNS), a strategic acquirer and developer of high-potential businesses in the Aerospace and Defense (A&D) sector, formerly Nukkleus Inc., today announced two senior leadership appointments aimed at strengthening execution, scalability, and long-term production reliability.
T3 Defense appointed Emil Blumer as Chief Business Officer and Jordan Buchler as Chief Executive Officer of its Manufacturing & Industrial Processing Division, aligning commercial growth and operational execution around the industrial capabilities that most directly influence production continuity.
As Chief Business Officer, Mr. Blumer is responsible...
Biotech Breakthroughs, Big Buyouts, Immunotherapy Momentum, and a Media Megamerger
Written by Customer Service on . Posted in Public Companies.
DENVER, Feb. 23, 2026 (GLOBE NEWSWIRE) — Wall Street opens to a convergence of science, scale, and strategic consolidation. From spider silk making mainstream headlines to multibillion-dollar oncology deals and accelerating immunotherapy revenues, today’s tape reflects capital flowing toward platforms with validation.
Kraig Biocraft Laboratories Featured on National Geographic Cover
Shares of Kraig Biocraft Laboratories (OTCQB:KBLB) could see elevated interest after the company’s recombinant spider silk technology landed on the cover of the March 2026 issue of National Geographic.The feature, The Quest for Spider Silk, spotlighted Kraig’s genetically enhanced silkworm platform, engineered to spin recombinant spider silk as part of the animal’s natural biological process. The coverage included facility tours and demonstrations...
